Charlemagne Capital as of Sept. 30, 2014
Portfolio Holdings for Charlemagne Capital
Charlemagne Capital holds 59 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Baidu (BIDU) | 17.0 | $24M | 108k | 218.24 | |
| Banco Itau Holding Financeira (ITUB) | 14.9 | $21M | 1.5M | 13.94 | |
| Petroleo Brasileiro SA (PBR.A) | 13.5 | $19M | 1.3M | 14.87 | |
| Banco Bradesco SA (BBD) | 5.3 | $7.4M | 520k | 14.28 | |
| Ambev Sa- (ABEV) | 5.2 | $7.2M | 1.1M | 6.56 | |
| Fomento Economico Mexicano SAB (FMX) | 4.4 | $6.1M | 66k | 92.15 | |
| TAL Education (TAL) | 4.3 | $5.9M | 170k | 34.97 | |
| Jd (JD) | 3.9 | $5.4M | 212k | 25.62 | |
| Grupo Televisa (TV) | 3.4 | $4.7M | 139k | 33.88 | |
| BRF Brasil Foods SA (BRFS) | 3.2 | $4.4M | 186k | 23.78 | |
| Companhia Brasileira de Distrib. | 2.8 | $3.8M | 88k | 43.71 | |
| Grupo Aval Acciones Y Valore (AVAL) | 2.7 | $3.8M | 278k | 13.59 | |
| Vale (VALE) | 2.7 | $3.7M | 338k | 10.99 | |
| 21vianet Group (VNET) | 2.3 | $3.2M | 176k | 17.98 | |
| Grana Y Montero S A A | 1.7 | $2.3M | 154k | 14.97 | |
| Credicorp | 1.6 | $2.2M | 15k | 153.27 | |
| Credicorp (BAP) | 1.6 | $2.2M | 14k | 153.29 | |
| Copa Holdings Sa-class A (CPA) | 1.6 | $2.2M | 20k | 107.54 | |
| Ultrapar Participacoes SA (UGP) | 1.4 | $1.9M | 90k | 21.11 | |
| Avianca Holdings Sa | 1.2 | $1.7M | 122k | 13.80 | |
| Johnson & Johnson (JNJ) | 0.5 | $718k | 6.7k | 106.88 | |
| Petroleo Brasileiro SA (PBR) | 0.4 | $562k | 40k | 14.17 | |
| Pfizer (PFE) | 0.4 | $550k | 19k | 29.68 | |
| Cosan Ltd shs a | 0.3 | $477k | 45k | 10.71 | |
| Merck & Co (MRK) | 0.3 | $438k | 7.4k | 59.49 | |
| Alibaba Group Holding (BABA) | 0.3 | $444k | 5.0k | 88.80 | |
| Gilead Sciences (GILD) | 0.3 | $428k | 4.0k | 106.47 | |
| Abbvie (ABBV) | 0.2 | $309k | 5.3k | 57.95 | |
| Thermo Fisher Scientific (TMO) | 0.2 | $247k | 2.0k | 122.28 | |
| Mylan | 0.2 | $234k | 5.1k | 45.75 | |
| Bristol Myers Squibb (BMY) | 0.2 | $227k | 4.4k | 51.28 | |
| Medivation | 0.2 | $227k | 2.3k | 98.95 | |
| Abbott Laboratories (ABT) | 0.1 | $213k | 5.1k | 41.68 | |
| Salix Pharmaceuticals | 0.1 | $188k | 1.2k | 157.06 | |
| Insulet Corporation (PODD) | 0.1 | $180k | 4.9k | 36.98 | |
| Medtronic | 0.1 | $169k | 2.7k | 62.18 | |
| Celgene Corporation | 0.1 | $167k | 1.8k | 95.10 | |
| Orexigen Therapeutics | 0.1 | $150k | 35k | 4.26 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $152k | 2.7k | 56.30 | |
| Illumina (ILMN) | 0.1 | $156k | 948.00 | 164.56 | |
| Allergan | 0.1 | $148k | 830.00 | 178.31 | |
| Becton, Dickinson and (BDX) | 0.1 | $120k | 1.1k | 114.29 | |
| Pharmacyclics | 0.1 | $110k | 937.00 | 117.40 | |
| Amgen (AMGN) | 0.1 | $95k | 675.00 | 140.74 | |
| Theravance Biopharma (TBPH) | 0.1 | $101k | 4.3k | 23.27 | |
| Stryker Corporation (SYK) | 0.1 | $85k | 1.0k | 81.18 | |
| Biogen Idec (BIIB) | 0.1 | $78k | 236.00 | 330.51 | |
| Theravance | 0.1 | $78k | 4.5k | 17.21 | |
| NPS Pharmaceuticals | 0.1 | $88k | 3.3k | 26.30 | |
| Impax Laboratories | 0.1 | $68k | 2.9k | 23.73 | |
| Quintiles Transnatio Hldgs I | 0.0 | $54k | 973.00 | 55.50 | |
| BioMarin Pharmaceutical (BMRN) | 0.0 | $48k | 664.00 | 72.29 | |
| Incyte Corporation (INCY) | 0.0 | $38k | 769.00 | 49.41 | |
| Regeneron Pharmaceuticals (REGN) | 0.0 | $38k | 105.00 | 361.90 | |
| Cubist Pharmaceuticals | 0.0 | $41k | 612.00 | 66.99 | |
| Genomic Health | 0.0 | $39k | 1.4k | 28.26 | |
| Nanostring Technologies (NSTGQ) | 0.0 | $45k | 4.1k | 11.03 | |
| Boston Scientific Corporation (BSX) | 0.0 | $27k | 2.3k | 11.94 | |
| Medicines Company | 0.0 | $22k | 970.00 | 22.68 |
